ALK vs. PXS, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, AAL, and GNK
Should you be buying Alkemy Capital Investments stock or one of its competitors? The main competitors of Alkemy Capital Investments include Provexis (PXS), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), and Greene King (GNK). These companies are all part of the "transportation" industry.
Alkemy Capital Investments vs.
Alkemy Capital Investments (LON:ALK) and Provexis (LON:PXS) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, community ranking, institutional ownership, analyst recommendations, dividends and risk.
1.5% of Alkemy Capital Investments shares are owned by institutional investors. Comparatively, 7.9% of Provexis shares are owned by institutional investors. 43.7% of Alkemy Capital Investments shares are owned by insiders. Comparatively, 21.6% of Provexis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Alkemy Capital Investments has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Alkemy Capital Investments' return on equity of 0.00% beat Provexis' return on equity.
In the previous week, Alkemy Capital Investments' average media sentiment score of 0.00 equaled Provexis'average media sentiment score.
Provexis has higher revenue and earnings than Alkemy Capital Investments.
Alkemy Capital Investments received 92 more outperform votes than Provexis when rated by MarketBeat users. Likewise, 76.88% of users gave Alkemy Capital Investments an outperform vote while only 64.21% of users gave Provexis an outperform vote.
Alkemy Capital Investments has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.
Summary
Alkemy Capital Investments beats Provexis on 6 of the 10 factors compared between the two stocks.
Get Alkemy Capital Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alkemy Capital Investments Competitors List
Related Companies and Tools
This page (LON:ALK) was last updated on 1/21/2025 by MarketBeat.com Staff
Free ALK Stock Alerts